41317-93-5Relevant articles and documents
Compound for treating or preventing hepatopathy (by machine translation)
-
Paragraph 0253-0254; 0255, (2019/10/01)
The invention discloses a compound, an optical isomer or a pharmaceutically acceptable salt, an optical isomer or a pharmaceutically acceptable salt thereof for treating or preventing hepatopathy, and the compound, optical isomer or pharmaceutically acceptable salt thereof can be applied to the preparation of a medicine for treating or preventing liver diseases. (by machine translation)
An effective system to synthesize hypolipidemic active α-asarone and related methoxylated (E)-arylalkenes
Sharma, Anuj,Joshi, Bhupendra P.,Sinha, Arun K.
, p. 2231 - 2235 (2007/10/03)
Methoxylated (E)-arylalkenes (1a-1k) were prepared in two steps by an improved Grignard reaction comprising the reverse addition of alkylmagnesium bromide to benzaldehydes (2a-2k) in anhydrous ether and toluene into arylalkanols (3a-3k) in high yield, followed by dehydration with silica gel under microwave irradiation for 3-12 min, depending upon the substituents attached to the aromatic ring to afford hypolipidemic active α-asarone (1a) and related methoxylated (E)-arylalkenes (1b-1k).